Board of Directors
Stephen H. Wise
Stephen H. Wise is a managing director and head of the Global Health Care team at The Carlyle Group. He is based in New York.
Mr. Wise currently serves as a member of the boards of directors of PPD, Albany Molecular Research, Inc., CorroHealth, MedRisk Holdco, LLC, Millicent Pharma Ltd., Ortho-Clinical Diagnostics, Rede D’Or São Luiz S.A., Sedgwick Inc., TriNetX, Inc. and WellDyneRx.
Prior to joining Carlyle, Mr. Wise worked with JLL Partners, a New York-based private equity firm, where he focused on health care-related investments. He reviewed and executed transactions in a wide variety of sectors, including facilities-based services, managed care and pharmaceutical services. Previously, he was with J.W. Childs Associates, a Boston-based private equity firm, and prior to that in the leveraged finance group of Credit Suisse.
Mr. Wise earned a bachelor’s degree in economics and finance from Bucknell University and received his MBA from the Harvard Business School.